4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-109391
Principal Financial Officer bought 2,500 shares at $5.30 ($13,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alfieri Michael Principal Financial Officer | 2025-08-13 | Purchase | +2,500 | $5.30 | $13,250 | 2,500 | D |
| Open-market purchases · 2,500 sh · avg $5.30 · $13,250 | |||||||
Loading xslF345X05/ownership.xml…